[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336692-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336692-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","malignant-pericardial-effusion-from-cervical-squamous-cell-carcinoma-a-case-study","Malignant Pericardial Effusion from Cervical Squamous Cell Carcinoma - A Case Study","","Rare malignant pericardial effusion is examined through a clinical case in which a 42-year-old woman previously treated for stage III cervical squamous cell carcinoma develops cough, fever, shortness of breath, and chest pain. Evaluation identifies pericardial effusion with spread to lungs and mediastinal/hilar lymph nodes. Cytology reveals malignant squamous cells compatible with metastatic disease, supported by immunohistochemistry positivity for p63 and p40 and negativity for multiple lineage markers. Clinical history and correlation establish the primary source as metastatic cervical cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/malignant-pericardial-effusion-from-cervical-squamous-cell-carcinoma-a-case-study/336692/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/malignant-pericardial-effusion-from-cervical-squamous-cell-carcinoma-a-case-study/336692.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What did the cytologic evaluation of the pericardial fluid show?","Question",{"text":63,"@type":64},"It showed malignant cells consistent with metastatic squamous cell carcinoma.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which immunohistochemistry markers supported the metastatic cervical squamous cell carcinoma diagnosis?",{"text":68,"@type":64},"Cells were positive for p63 and p40, and negative for GATA-3, D2-40, calretinin, and WT1.",{"name":70,"@type":61,"acceptedAnswer":71},"Why should malignant pericardial effusion with squamous cells prompt consideration of cervical cancer?",{"text":72,"@type":64},"Because history and clinical correlation are crucial for identifying the primary site, and pericardial metastasis from cervical cancer, though uncommon, should be included among potential diagnoses—especially with high-grade invasive tumors, recurrences, or distant metastases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336692,1790835758,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":97,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","e-ISSN 1941-5923  \n© Am J Case Rep, 2024; 25: e943013 DOI: 10. 12659/AJCR.943013  \nReceived: 2024.10.29  \nAccepted: 2024.02.08  \nAvailable online: 2024.07.18  \nPublished: 2024.08.28  \nAuthors’ Contribution: Study Design A  \nData Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G  \nAEF  \nEF  \nAB  \nE  \nE  \nE  \nA  \nAE  \nCorresponding Author: Financial support: Conflict of interest:  \nMalignant Pericardial Effusion from Cervical Squamous Cell Carcinoma: A Case Study  \n1 Sunder Sham  \n2 Saroja Devi Geetha  \n3 Alae Kawam  \n1 Ahmed Bendari  \n1 Reham Al-Refai  \n4 F.N.U. Anjali  \n1 Manju Harshan  \n2 Kasturi Das  \nSunder Sham, e-mail: [drsundersham@gmail.com](drsundersham@gmail.com)  \nNone declared  \nNone declared  \n1 Department of Pathology and Laboratory Medicine, Northwell, Health Lenox Hill Hospital, New York City, NY, USA  \n2 Department of Pathology and Laboratory Medicine, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, Northwell Health, Greenvale, NY, USA  \n3 Department of Pathology and Laboratory Medicine, Ameripath/Quest, Indianapolis, IN, USA  \n4 Department of Pathology and Laboratory Medicine, Sakhi Baba General Hospital, Sindh, Pakistan  \nPatient: Female, 42-year-old  \nFinal Diagnosis: Metastatic squamous cell carcinoma  \nSymptoms: Cough • fever • shortness of breath  \nClinical Procedure: —  \nSpecialty: Pathology  \nObjective: Rare coexistence of disease or pathology  \nBackground: Cervical cancer ranks fourth globally among women’s cancers. Squamous cell carcinoma constitutes 70% of cervical cancer cases, often metastasizing to lungs and paraaortic nodes. Uncommon sites include the brain, skin, spleen, and muscle, while pericardial fluid metastasis is highly rare. We report a case of squamous cell carcinoma of the uterine cervix that was metastatic to the pericardium and was detected on cytologic evaluation of pericardial fluid.  \nCase Report: A 42-year-old woman who was previously treated for stage III squamous cell carcinoma of the cervix presented with symptoms of cough, fever, and shortness of breath for 8 days, and chest pain for 3 days. Clinical workup revealed pericardial effusion, with spread to the lungs and mediastinal and hilar lymph nodes. Cytological analysis of the fluid showed malignant cells, consistent with metastatic squamous cell carcinoma. Immunohistochemistry demonstrated cells positive for p63 and p40, while negative for GATA-3, D2-40, calretinin, and WT1. These findings in conjunction with patient’s known history of cervical squamous cell carcinoma was consistent with a cytologic diagnosis of metastatic squamous cell carcinoma to pericardial fluid.  \nConclusions: History and clinical correlation plays a vital role in determining the primary site causing malignant pericardial effusions. While the occurrence of cervical cancer metastasizing to the pericardium is uncommon, it should be considered, particularly in cases involving high-grade, invasive tumors, recurrences, or distant metastases. This possibility should be included in the list of potential diagnoses when encountering pericardial effusions with squamous cells in female patients.  \nKeywords: Neoplasm Metastasis • Neoplasms, Squamous Cell • Pericardial Effusion • Uterine Cervical Neoplasms  \nFull-text PDF: [https://www.amjcaserep.com/abstract/index/idArt/943013](https://www.amjcaserep.com/abstract/index/idArt/943013)  \n1243  1  5  22  \nPublisher’s note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher  \nThis work is licensed under Creative Common AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)  \ne943013-1  \nIndexe","cbCaibOEbCF7zNwQ","https://ap.wps.com/l/cbCaibOEbCF7zNwQ","pdf",1213770,"English","# Case Report\n## Diagnosis and Clinical Findings\n## Immunohistochemistry and Cytology\n## Conclusions","[{\"question\":\"What did the cytologic evaluation of the pericardial fluid show?\",\"answer\":\"It showed malignant cells consistent with metastatic squamous cell carcinoma.\"},{\"question\":\"Which immunohistochemistry markers supported the metastatic cervical squamous cell carcinoma diagnosis?\",\"answer\":\"Cells were positive for p63 and p40, and negative for GATA-3, D2-40, calretinin, and WT1.\"},{\"question\":\"Why should malignant pericardial effusion with squamous cells prompt consideration of cervical cancer?\",\"answer\":\"Because history and clinical correlation are crucial for identifying the primary site, and pericardial metastasis from cervical cancer, though uncommon, should be included among potential diagnoses—especially with high-grade invasive tumors, recurrences, or distant metastases.\"}]","Malignant Pericardial Effusion from Cervical Squamous Cell Carcinoma - A Case Study | PDF",1790016200,13,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6bb81bdb45c6d2460b1b1a808c580fa.webp",983,1376,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1a5feee6efcbc2a61c70b4a8d62fe4b.webp",982,1374,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eefef524fa4316fb2ab809468aae4b33.webp",981,1373,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49c84a19fe01a466fe5e1c35ec60dbca.webp",980,1372]